GLP-1s Bringing Back Scurvy? Achondroplasia Drug Win; Intermittent Fasting Flop

(MedPage Today) — The meteoric rise in GLP-1 weight-loss drugs has raised concerns about potential malnutrition and even the return of scurvy. (The Hill) An $80-a-month subsidy for prescription products failed to improve cardiometabolic health…